Prima BioMed Carves A Niche In Busy IO Pipeline
Executive Summary
Emerging Company Profile: Prima BioMed, a biotech developing immuno-oncology medicines, has been patiently waiting in the wings. Now, with three of its LAG-3 drug candidates partnered with pharma players, the company is ready to take center stage.